We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Image: The collaboration between Heidelberg Epignostix and the NHS Genomic Medicine Service (GMS) establishes a national framework spanning each of the NHS GMS Genomic Laboratory testing service. (Image Credit: Heidelberg Epignostix)

New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers

A new partnership now brings clinically validated epigenetic tumor classifiers into NHS genomic laboratory services across England.  More...
02 Sep 2026
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

An AI approach integrates stool microbiome data across methods to score colorectal cancer. More...
02 Sep 2026
Image Credit: Adobe Stock

New Cellular Map May Help Predict Crohn’s Disease Course in Children

A new single-cell map of pediatric Crohn’s disease helps predict response to anti-TNF therapy More...
02 Sep 2026
Image Credit: Adobe Stock

New Cellular Map May Help Predict Crohn’s Disease Course in Children

A new single-cell map of pediatric Crohn’s disease helps predict response to anti-TNF therapy More...
02 Sep 2026
Image: The Lumipulse G NfL Blood assay provides a reliable method for the quantitative measurement of neurofilament light chain NfL in serum and plasma (Photo courtesy of Fujirebio)

Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada

Health Canada has issued Class II Medical Device Licenses for Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma on the fully automated LUMIPULSE G platform. More...
02 Sep 2026
Image: A research team led by Prof. Hsing I-Ming (center), Professor of the Department of Chemical and Biological Engineering at HKUST, has developed TEMPO, a thermodynamically programmed one-pot CRISPR platform for rapid, point-of-care nucleic acid testing. Mr. Wu Xiaolong (third right) and Ms. Li Yanan (first left), PhD students from the Department of Chemical and Biological Engineering, are the co-first authors of this study. (Photo courtesy of HKUST)

Single-Tube CRISPR Test Detects Pathogens and Genetic Variants in 30 Minutes

A new one-pot CRISPR test detects pathogens and genetic variants in 30 minutes with ultra-high sensitivity More...
01 Sep 2026
Image Credit: 123RF

NIH-Funded Study Targets Saliva-Based Long COVID Diagnosis

An AI approach analyzes salivary biomarkers to support long COVID diagnosis and predict risk of persistent symptoms. More...
01 Sep 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Hematology Consumables
Bioblood Devices
New
Gold Member
POCT RT-qPCR Analyzer
BG-X6
Copyright © 2000-2026 Globetech Media. All rights reserved.